[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635679":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":13,"armGroups":25,"interventions":35,"overallOfficials":13,"centralContacts":39,"locations":50,"responsibleParty":63,"collaborators":13,"id":68,"slug":13,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":13,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":13,"studyType":80,"phases":81,"briefSummary":84,"conditions":85,"keywords":13,"overallStatus":87,"whyStopped":13,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"South Egypt Cancer Institute","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"effectiveness of SPGB with bupivacaine and dexmedetomidine for postoperative analgesia","Numeric rating scale for pain will be assessed and recorded within the first 24 hours where 1 means the worst pain and 10 means no pain. Total rescue analgesia in 24 H when Numeric rating scale ≥ 4 was recorded and the first time when it was given will be recorded.","6 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","FACTORIAL","SUPPORTIVE_CARE",{"masking":19,"maskingDescription":13,"whoMasked":20},"QUADRUPLE",[21,22,23,24],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[26,32],{"label":27,"type":28,"description":29,"interventionNames":30},"group a","EXPERIMENTAL","Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine",[31],"Drug: Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine",{"label":33,"type":28,"description":29,"interventionNames":34},"druop b",[31],[36],{"type":37,"name":29,"description":29,"armGroupLabels":38,"otherNames":13},"DRUG",[33,27],[40,46],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Sara Mansour Mansour","CONTACT","1061092528","0020","saram@aun.edu.eg",{"name":47,"role":42,"phone":48,"phoneExt":44,"email":49},"Ahmed Kamal Attia","1010677881","ahmedkamal86anathesia@gmail.com",[51],{"facility":52,"status":13,"city":53,"state":13,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":13},"Assiut university hospital","Asyut","161715","Egypt","EG",{"type":58,"coordinates":59},"Point",[60,61],31.18368,27.18096,{"lat":61,"lon":60},{"type":64,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":67,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","Ahmed Kamal Sayed","anesthesia consultant","Assiut University","100635679",false,"NCT07555821","Improving Postoperative Analgesia After Functional Endoscopic Surgery","Improving Postoperative Analgesia After Functional Endoscopic Surgery: Sphenopalatine Ganglion Block Versus Soaked Nasal Packing Using Bupivacaine and Dexmedetomidine","Inclusion Criteria:\n\n1. Age 18 - 60 years\n2. ASA physical status I -II\n3. Patients scheduled for elective FESS\n\nExclusion Criteria:\n\n1. Allergy to drugs used\n2. Coagulopathy or anticoagulant therapy\n3. Severe cardiovascular, renal and hepatic disease\n4. Chronic opioid use Pregnancy","ALL","18 Years","60 Years",{"count":78,"type":79},20,"ESTIMATED","INTERVENTIONAL",[82,83],"PHASE2","PHASE3","Improving postoperative analgesia after functional endoscopic surgery: Sphenopalatine ganglion block versus soaked nasal packing using bupivacaine and dexmedetomidine",[86],"Pain Management After Functional Endoscopic Sinuscopy","NOT_YET_RECRUITING","2026-04-21",{"date":90,"type":91},"2026-04-29","ACTUAL",{"date":93,"type":79},"2026-04-15",{"date":95,"type":79},"2026-10-30",{"name":5,"class":6},1]